Jiangsu Apon Medical Technology Stock Forum

Investors expect the company's growth to lag behind the industry, reflecting in its low P/S ratio. Limited growth rates are anticipated to persist, reducing stock value. If revenue trends continue, share price recovery seems unlikely.